MDT stock verdict - Growth
MDT
Medtronic plc
GROWTHHealthcare
$88.64
Strong Buy
$88.64
Heavy$96.61Buy$128.81Fair$161.01Exit$193.21
VALUE74
GROWTH32
QUALITY96
TECHNICAL—
TRUST SCORE
100High
confidence in this read — data completeness, earnings quality & coverage
Technicals: insufficient price history
PROS
- Trades 45% below the model's fair value ($161.01)
- Reasonable forward P/E of 13.8× on analyst estimates
- Conservative balance sheet — debt-to-equity of 0.49
- Converts 16% of revenue into free cash flow
- High gross margin of 65% (3-yr avg)
CONS
No red flags detected.
✳ Pros and cons are machine-generated from the latest fundamentals and technicals.
EARNINGS QUALITY · we check the accounting so you don't have to
✓Operating cash flow is 154% of net income — profit is backed by real cash
Analysis as of 2026-09-25 · price live, fundamentals from latest filings
Congress Trading — last 90 days
See what senators are buying and selling on MDT. Sign in to unlock.
📊 Options Flow — Put/Call Ratio
FAQ
Why is MDT rated Growth?
MDT (Medtronic plc) is rated Growth because the model combines fundamentals, price action, and earnings-quality checks. The current signal is Strong Buy. Trades 45% below the model's fair value ($161.01) and Reasonable forward P/E of 13.8× on analyst estimates
Is MDT overvalued right now?
MDT is trading at $88.64 versus an estimated fair value of $161.01. That puts the stock in growth territory on this framework. The page shows the specific downside checks behind that call.
What should I watch before acting on MDT?
Watch the trust score of 100, the earnings-quality checks, and any red flags. The page includes the key cautions and a plain-English summary.